SCHEDULE 13G/A 0001232621 XXXXXXXX LIVE 2 Common Stock, par value $0.0001 per share 03/31/2025 0001783032 Elevation Oncology, Inc. 28623U101 101 Federal Street Suite 1900 Boston MA 02110 Rule 13d-1(c) TANG CAPITAL MANAGEMENT, LLC DE 0.00 6043921.00 0.00 6043921.00 6043921.00 N 9.99 OO Tang Capital Management, LLC ("TCM") beneficially owns 6,043,921 shares of the Issuer's Common Stock, which consists of: (i) 4,760,000 shares of the Issuer's Common Stock and (ii) 1,283,921 shares currently issuable upon exercise of Warrants (the "Warrants," as defined in the Issuer's Prospectus filed pursuant to Rule 424(b)(5) with the Securities and Exchange Commission on June 9, 2023). The percentages used herein are based on 60,499,716 shares of Common Stock outstanding, which is comprised of: (i) 59,215,795 shares of Common Stock outstanding as of February 28, 2025, as set forth in the Issuer's Annual Report filed on Form 10-K that was filed with the Securities and Exchange Commission on March 6, 2025 and (ii) 1,283,921 shares currently issuable upon exercise of Warrants. TCM shares voting and dispositive power over such shares with Tang Capital Partners, LP ("TCP"), Tang Capital Partners International, LP ("TCPI"), Tang Capital Partners III, Inc ("TCP III") and Kevin Tang. KEVIN TANG X1 0.00 6043921.00 0.00 6043921.00 6043921.00 N 9.99 IN Kevin Tang beneficially owns 6,043,921 shares of the Issuer's Common Stock, which consists of: (i) 4,760,000 shares of the Issuer's Common Stock and (ii) 1,283,921 shares currently issuable upon exercise of Warrants. Kevin Tang shares voting and dispositive power over such shares with TCP, TCPI, TCP III and TCM. TANG CAPITAL PARTNERS, LP DE 0.00 5052545.00 0.00 5052545.00 5052545.00 N 8.35 PN TCP beneficially owns 5,052,545 shares of the Issuer's Common Stock, which is comprised of: (i) 3,768,624 shares of Common Stock and (ii) 1,283,921 shares currently issuable upon exercise of Warrants. TCP owns 3,750,000 of the Issuer's Warrants, which are each exercisable for one share of the Issuer's Common Stock. The Warrants are immediately exercisable and expire five years from the date of issuance. TCP may not exercise any portion of the Warrants for shares of Common Stock if, as a result of the exercise, TCP, together with its affiliates and any other person or entity acting as a group, would own more than 9.99% of the Issuer's outstanding shares of Common Stock after exercise. The foregoing limitations remain in effect with respect to the Warrants, and, accordingly, only 1,283,921 shares are currently issuable upon exercise of the Warrants. TCP shares voting and dispositive power over such shares with TCM and Kevin Tang. TANG CAPITAL PARTNERS INTERNATIONAL, LP DE 0.00 551376.00 0.00 551376.00 551376.00 N 0.91 PN TCPI shares voting and dispositive power over such shares with TCM and Kevin Tang. TANG CAPITAL PARTNERS III, INC NV 0.00 440000.00 0.00 440000.00 440000.00 N 0.73 CO TCP III shares voting and dispositive power over such shares with TCM and Kevin Tang. TANG CAPITAL PARTNERS IV, INC NV 0.00 0.00 0.00 0.00 0.00 N 0.0 CO Elevation Oncology, Inc. 101 Federal Street, Suite 1900, Boston, MA, 02110 This Statement on Schedule 13G (this "Statement") is filed by TCM, the general partner of TCP and TCPI; Kevin Tang, the manager of TCM and Chief Executive Officer of TCP III and Tang Capital Partners IV, Inc. ("TCP IV"); TCP; TCPI; TCP III; and TCP IV. The address of TCM, Kevin Tang, TCP and TCPI is 4747 Executive Drive, Suite 210, San Diego, CA 92121. The address of TCP III and TCP IV is 400 S. 4th Street, 3rd Floor, Las Vegas, NV 89101. TCM is a Delaware limited liability company. Mr. Tang is a United States citizen. TCP and TCPI are Delaware limited partnerships. TCP III and TCP IV are Nevada corporations that are indirectly wholly owned by TCP. Y 6,043,921 9.99% 0 shares 6,043,921 shares 0 shares 6,043,921 shares Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. TANG CAPITAL MANAGEMENT, LLC /s/ Kevin Tang 05/15/2025 KEVIN TANG /s/ Kevin Tang 05/15/2025 TANG CAPITAL PARTNERS, LP /s/ Kevin Tang 05/15/2025 TANG CAPITAL PARTNERS INTERNATIONAL, LP /s/ Kevin Tang 05/15/2025 TANG CAPITAL PARTNERS III, INC /s/ Kevin Tang 05/15/2025 TANG CAPITAL PARTNERS IV, INC /s/ Kevin Tang 05/15/2025